# Ery-Ped

NDC: 80005-155
Generic name: Erythromycin Ethylsuccinate
Labeler / Manufacturer: Carnegie Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20250115

FDA application: NDA050207

## Active ingredients

- ERYTHROMYCIN ETHYLSUCCINATE: 400 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80005-155"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80005-155
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94b4658c-f4f5-4257-a1e3-82fd3155dee6